← Open Payments lookup

BRIAN FINLEY: Open Payments

NPI 1144278482 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,216 in 129 payments from 26 companies in 2025. Trend: 2023 $3,111 · 2024 $3,608 · 2025 $3,216

Food & beverage: $3,216
CompanyPaymentsAmount
ABBVIE INC.26$759
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$486
AstraZeneca Pharmaceuticals LP9$288
Vanda Pharmaceuticals Inc.6$215
Lundbeck LLC9$208
E.R. Squibb & Sons, L.L.C.5$203
Otsuka America Pharmaceutical, Inc.11$138
Supernus Pharmaceuticals, Inc.2$137
Axsome Therapeutics, Inc.6$116
Lilly USA, LLC7$110

Products named: CAPLYTA, VRAYLAR, REXULTI, QULIPTA, COBENFY, FANAPT, BREZTRI, Qelbree.

Industry payments across NE — which companies pay providers there.